Global Multiple Sclerosis Therapeutics Market Analysis to 2029 – Featuring Teva Pharmaceuticals, Pfizer and Novartis Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Multiple Sclerosis Therapeutics Market Analysis by Drug Class (Immunosuppressant, Immunomodulators) By Mode of Administration (Injectable, Oral, Intravenous) and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The global multiple sclerosis therapeutics market size is estimated to be USD 27.84 billion in 2020 and is expected to witness a CAGR of 6.71% during the forecast period.

Increasing global prevalence of target disease is a key driver for the growth of the global multiple sclerosis therapeutics market.

Additionally, awareness programs regarding benefits of multiple sclerosis therapeutics for the treatment of target diseases and favorable reimbursement policies are some of the other drivers propelling the market growth.

Nevertheless, side-effects and risks associated with multiple sclerosis therapeutics and indeterminate etiology of the disease are expected to restrain the global market growth.

Companies Mentioned

• Teva Pharmaceuticals (Israel)
• Pfizer (U.S.)
• Biogen Idec (U.S.)
• Bayer Healthcare (Germany)
• Genzyme (SANOFI) (U.S.)
• Merck & Co. (U.S.)
• Novartis (Switzerland)
• Bristol Myers Squibb (U.S.)
• Horizon Therapeutics (Dublin)
• Takeda Pharmaceutical Company (Japan)

The multiple sclerosis therapeutics market report is categorized into the following segments and subsegments:

Multiple Sclerosis Therapeutics Market, By Drug Class (Revenue, 2021-2029, USD Billion)

• Immunosuppressant
• Immunomodulators

Multiple Sclerosis Therapeutics Market, By Mode of Administration (Revenue, 2021-2029, USD Billion)

• Injectable
• Oral
• Intravenous

Multiple Sclerosis Therapeutics Market, By Region (Revenue, 2021-2029, USD Billion)

North America

• U.S.
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• Saudi Arabia
• Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/fqfwj1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900